Literature DB >> 3207974

Investigations into the origin of the high pressure neurological syndrome: the interaction between pressure, strychnine and 1,2-propandiols in the mouse.

F Bowser-Riley1, S Daniels, E B Smith.   

Abstract

1. The effects of a variety of structural isomers of the centrally acting muscle relaxant mephenesin on the high pressure neurological syndrome have been investigated. Threshold pressures for the onset of the behavioural signs, tremors and convulsions, were established. The effects of these compounds on the response to pressure were also compared with their ability to antagonize the convulsive action of strychnine. 2. The dose-response relationships for strychnine and picrotoxin were investigated at fixed pressures. Additionally, the dose-response relationship of strychnine, in the presence of mephenesin, at pressure was investigated. 3. All the isomers of mephenesin protected against the effects of both pressure and strychnine. The relative potency was found to be identical with respect to both. Mephenesin was clearly the most effective; it raised the threshold pressure for tremors by 2.5 times, that for convulsions elicited by pressure by 1.5 and the ED50 for strychnine convulsions by 1.6 times. Strychnine was found to be strictly additive with pressure whereas picrotoxin exhibited gross deviations from additivity. Mephenesin ameliorated the combined effects of pressure and strychnine equally. 4. The marked dependence on structure of the anticonvulsant activity of the mephenesin isomers can be interpreted as evidence that pressure acts not by some general perturbation of the membranes of excitable cells but rather via some specific interaction. The finding that strychnine and pressure are strictly additive supports the idea of specificity and also indicates that they may share a common mechanism in the production of convulsions. By analogy with the established mechanism of action of strychnine, it is suggested that the hyperexcitability associated with pressure might arise from an action on glycine-mediated inhibitory processes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3207974      PMCID: PMC1854086          DOI: 10.1111/j.1476-5381.1988.tb11624.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  PRESYNAPTIC INHIBITION IN THE SPINAL CORD.

Authors:  J C ECCLES
Journal:  Prog Brain Res       Date:  1964       Impact factor: 2.453

2.  Central depressant and anticonvulsant properties of glycerol ethers isomeric with mephenesin.

Authors:  F M BERGER
Journal:  J Pharmacol Exp Ther       Date:  1952-08       Impact factor: 4.030

3.  Mechanistic studies on the high pressure neurological syndrome.

Authors:  F Bowser-Riley
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1984-01-07       Impact factor: 6.237

4.  2-Amino-phosphonoheptanoic acid protects against the high pressure neurological syndrome.

Authors:  B Meldrum; B Wardley-Smit; M Halsey; J C Rostain
Journal:  Eur J Pharmacol       Date:  1983-03-04       Impact factor: 4.432

Review 5.  The nature of the site of general anesthesia.

Authors:  K W Miller
Journal:  Int Rev Neurobiol       Date:  1985       Impact factor: 3.230

Review 6.  Amino acid transmitters in the mammalian central nervous system.

Authors:  D R Curtis; G A Johnston
Journal:  Ergeb Physiol       Date:  1974

7.  Effect of compression rate on use of trimix to ameliorate HPNS in man to 686 m (2250 ft).

Authors:  P B Bennett; R Coggin; M McLeod
Journal:  Undersea Biomed Res       Date:  1982-12

8.  Drugs that increase gamma-aminobutyric acid transmission protect against the high pressure neurological syndrome.

Authors:  A R Bichard; H J Little
Journal:  Br J Pharmacol       Date:  1982-07       Impact factor: 8.739

9.  Effect of excitatory amino acid antagonists on the high pressure neurological syndrome in rats.

Authors:  B Wardley-Smith; B S Meldrum
Journal:  Eur J Pharmacol       Date:  1984-10-15       Impact factor: 4.432

10.  Production of endolymph in the semicircular canal of the frog Rana esculenta.

Authors:  C Bernard; E Ferrary; O Sterkers
Journal:  J Physiol       Date:  1986-02       Impact factor: 5.182

View more
  3 in total

1.  An evaluation of the structure-activity relationships of a series of analogues of mephenesin and strychnine on the response to pressure in mice.

Authors:  F Bowser-Riley; S Daniels; W A Hill; E B Smith
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

2.  Targets for ethanol action and antagonism in loop 2 of the extracellular domain of glycine receptors.

Authors:  Daya I Perkins; James R Trudell; Daniel K Crawford; Ronald L Alkana; Daryl L Davies
Journal:  J Neurochem       Date:  2008-05-12       Impact factor: 5.372

3.  Possible NMDA antagonist properties of drugs that affect high pressure neurological syndrome.

Authors:  M A Shuker; F Bowser-Riley; S N Davies
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.